These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30640686)

  • 1. The effect of introducing pelvic lymphadenectomy on survival and recurrence rates in Danish endometrial cancer patients at high risk: a Danish Gynecological Cancer Group study.
    Ørtoft G; Høgdall C; Juhl C; Petersen LK; Hansen ES; Dueholm M
    Int J Gynecol Cancer; 2019 Jan; 29(1):68-76. PubMed ID: 30640686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival advantage of lymphadenectomy in endometrial cancer.
    Eggemann H; Ignatov T; Kaiser K; Burger E; Costa SD; Ignatov A
    J Cancer Res Clin Oncol; 2016 May; 142(5):1051-60. PubMed ID: 26746654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of patients with stage IIIC endometrial cancer.
    Turan T; Ureyen I; Duzguner I; Ozkaya E; Tasci T; Karalok A; Boran N; Kose MF; Tulunay G
    Int J Gynecol Cancer; 2014 Jul; 24(6):1033-41. PubMed ID: 24905617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 10-year results after national introduction of pelvic lymph node staging in Danish intermediate-risk endometrial cancer patients not given postoperative radiotherapy.
    Ørtoft G; Høgdall C; Hansen ES; Dueholm M
    Eur J Obstet Gynecol Reprod Biol; 2021 Aug; 263():239-246. PubMed ID: 34247041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management and Survival of Elderly and Very Elderly Patients with Endometrial Cancer: An Age-Stratified Study of 1228 Women from the FRANCOGYN Group.
    Poupon C; Bendifallah S; Ouldamer L; Canlorbe G; Raimond E; Hudry N; Coutant C; Graesslin O; Touboul C; Collinet P; Bricou A; Huchon C; Daraï E; Ballester M; Levêque J; Lavoue V
    Ann Surg Oncol; 2017 Jun; 24(6):1667-1676. PubMed ID: 28008573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic para-aortic and pelvic lymphadenectomy in early stage epithelial ovarian cancer: a prospective study.
    Ditto A; Martinelli F; Reato C; Kusamura S; Solima E; Fontanelli R; Haeusler E; Raspagliesi F
    Ann Surg Oncol; 2012 Nov; 19(12):3849-55. PubMed ID: 22707110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival and recurrence in stage II endometrial cancers in relation to uterine risk stratification after introduction of lymph node resection and omission of postoperative radiotherapy: a Danish Gynecological Cancer Group Study.
    Ørtoft G; Høgdall C; Hansen ES; Dueholm M
    J Gynecol Oncol; 2020 Mar; 31(2):e22. PubMed ID: 31912677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival.
    Bristow RE; Zahurak ML; Alexander CJ; Zellars RC; Montz FJ
    Int J Gynecol Cancer; 2003; 13(5):664-72. PubMed ID: 14675352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the lymphadenectomy in high-risk histologic types of endometrial cancer: a matched-pair study.
    Coronado PJ; Fasero M; Baquedano L; Martinez-Maestre MA; Casado A; Vidart JA; Herraiz MA
    Int J Gynecol Cancer; 2014 May; 24(4):703-12. PubMed ID: 24651627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
    Gasimli K; Braicu EI; Nassir M; Richter R; Babayeva A; Chekerov R; Darb-Esfahani S; Sehouli J; Muallem MZ
    Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
    Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
    J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
    Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N
    Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival impact of lymphadenectomy stratified by nodal metastatic probability in endometrial cancer.
    Koskas M; Fournier M; Luton D; Darai E; Rouzier R
    Ann Surg Oncol; 2014 Jul; 21(7):2376-82. PubMed ID: 24590435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Location of recurrences in high-risk stage Iendometrial cancer patients not given postoperative radiotherapy: A Danish gynecological cancer group study.
    Ørtoft G; Høgdall C; Juhl C; Petersen LK; Hansen ES; Dueholm M
    Int J Gynecol Cancer; 2019 Mar; 29(3):497-504. PubMed ID: 30833438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of vaginal brachytherapy in the treatment of surgical stage I papillary serous or clear cell endometrial cancer.
    Barney BM; Petersen IA; Mariani A; Dowdy SC; Bakkum-Gamez JN; Haddock MG
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):109-15. PubMed ID: 22543202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between retroperitoneal lymphadenectomy and survival in advanced ovarian cancer patients.
    Fang C; Zhang Y; Zhao L; Chen X; Xia L; Zhang P
    BMC Cancer; 2020 Jul; 20(1):654. PubMed ID: 32660444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of body mass index on surgical outcomes and analysis of disease recurrence for patients with endometrial cancer undergoing robotic-assisted staging.
    Menderes G; Azodi M; Clark L; Xu X; Lu L; Ratner E; Schwartz PE; Rutherford TJ; Santin AD; Silasi DA
    Int J Gynecol Cancer; 2014 Jul; 24(6):1118-25. PubMed ID: 24927247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival after stage IA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey.
    Lajer H; Elnegaard S; Christensen RD; Ortoft G; Schledermann DE; Mogensen O
    Acta Obstet Gynecol Scand; 2012 Aug; 91(8):976-82. PubMed ID: 22548255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival implications of staging lymphadenectomy for non-endometrioid endometrial cancers.
    Venigalla S; Chowdhry AK; Shalowitz DI
    Gynecol Oncol; 2018 Jun; 149(3):531-538. PubMed ID: 29559170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early-stage Uterine Pure and Mixed Clear Cell Carcinoma: Outcomes and Recurrence With and Without Adjuvant Therapy.
    Chang-Halpenny CN; Natarajan S; Hwang-Graziano JM
    Am J Clin Oncol; 2018 Apr; 41(4):371-378. PubMed ID: 26950465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.